Brn-4 is a member of the POU transcription factor family and is expressed in the central nervous system. In this study, we addressed whether Brn-4 regulates expression of the DtA dopamine receptor gene. We found a functional Brn-4 responsive element in the intron of this gene by means of cotransfection chloramphenical acetyltransferase assays. This region contains two consensus sequences for binding of POU factors. Gel mobility-shift assays using glutathione S-transferase-Brn-4 fusion protein indicated that Brn-4 binds to these sequences. Both these sites are essential for transactivation by Brn-4 because deletion of either significantly reduced this enhancer activity. In situ hybridization revealed colocalization of Brn-4 and DlA mRNAs at the level of a single neuron in the rat striatum where this dopamine receptor is most abundantly expressed. Gel mobility-supershift assay using rat striatal nuclear extract and Brn-4 antibody confirmed the presence ofBrn-4 in this brain region and its ability to bind to its consensus sequences in the DlA gene. These data suggest a functional role for Brn-4 in the expression of the DIA dopamine receptor gene both in vitro and in vivo.
Brn-4 responsive element in the intron of this gene by means of cotransfection chloramphenical acetyltransferase assays. This region contains two consensus sequences for binding of POU factors. Gel mobility-shift assays using glutathione S-transferase-Brn-4 fusion protein indicated that Brn-4 binds to these sequences. Both these sites are essential for transactivation by Brn-4 because deletion of either significantly reduced this enhancer activity. In situ hybridization revealed colocalization of Brn-4 and DlA mRNAs at the level of a single neuron in the rat striatum where this dopamine receptor is most abundantly expressed. Gel mobility-supershift assay using rat striatal nuclear extract and Brn-4 antibody confirmed the presence ofBrn-4 in this brain region and its ability to bind to its consensus sequences in the DlA gene. These data suggest a functional role for Brn-4 in the expression of the DIA dopamine receptor gene both in vitro and in vivo.
POU transcription factors share a common bipartite DNA- binding domain that comprises an N-terminal POU-specific domain and a C-terminal homeodomain (1) . Although the homeodomain is sufficient for recognizing specific DNA sequences, the POU-specific domain increases the binding affinity to the elements (2) (3) (4) . POU members are expressed from the early embryo to adulthood in chronologically and topologically specific manners. Oct-3/4 is expressed in germ line cells and quickly disappears at the early embryo stage (5) (6) (7) . On the other hand, POU-III subclass genes that include Brn-1, Bm-2 (8, 9), Bm-4/ RHS2 (10, 11) and Tst-1/transcriptional repressor of myelinspecific genes/Oct-6 (9, (12) (13) (14) as well as POU-IV subclass genes that include Brn3.0/Brn-3 (9, 15) and Brn-3.2 (16) display specific and restricted expression patterns in the central nervous system (reviewed in refs. 17 and 18) . These findings suggest that various POU family members play important roles in the central nervous system. POU factors regulate specific molecules in the nervous system. In nonvertebrates, Cfla regulates the expression of Drosophila dopa decarboxylase (19) . In vertebrates, Pit-1 regulates prolactin and growth hormone gene expression in neuroendocrine cells (20) (21) (22) , and a mutation in the human PIT-1 gene results in combined deficiency of prolactin and growth hormone leading to dwarfism (23) (24) (25) . Another POU factor, SCIP/Tst-l/Oct-6, modulates expression of the a3 acetylcholine receptor subunit gene and the P0 myelin gene (12, 13, (26) (27) (28) (29) . Despite the large number of POU transcription factors expressed in the central nervous system, information about their functions in neurons is limited. Additional knowledge about the relationship between POU factors and their neuronal target molecules is essential for a better understanding of the roles that these transcription factors play during brain development and in the adult organism. Since gene disruption studies evaluate the net outcome in the presence of other genes acting alternatively on the same biological system, we took classical approaches in this investigation to assess one of the functions of a specific POU transcription factor.
We previously reported that the human DlA dopamine receptor gene is transcribed from a G+C-rich promoter (30) and is modulated by upstream activators to which as yet unknown transcription factors bind (31) . It is noteworthy that the transcriptional activity of this gene is relatively strong even when the sequence 5' to the core promoter is very short (30) . Clusters of A+T-rich sequences are located among G+C-rich regions around the core promoter. We, therefore, tested whether POU transcription factors, which preferentially bind to A+T-rich sequence motifs (18) , can modulate expression of the human DIA gene. Bm-4 was selected as a candidate for this analysis because it is the most abundantly expressed POU factor in the striatum (9, 10). We found evidence for two functional Brn-4 responsive elements in the intron of the-DlA gene in both cultured neuroblastoma cells and in the rat striatum.
MATERIALS AND METHODS
Construction of Plasmids. Effector plasmids were made by subcloning the full-length cDNA of Bm-4 and Brn-2 into a eukaryotic expression vector directed by the cytomegalovirus (CMV) promoter (32) . DD Seven additional oligonucleotides were synthesized to construct reporter plasmids having internal deletions of the POU responsive elements PRE1 and PRE2 and of the AP2 consensus sequence. These primers were mDX1, 5'-AATCTA-GAGCCCGTCCGAGCCACCTA-3' (-581 to -598); mDX2, 5'-AATCTAGAGAATTATTAGGTTGGGCT-3' (-571 to -554); mDX3, 5'-AATCTAGACGTCAAGCCCAAC-CTAAT-3' (-549 to -566); mDX4, 5'-AATCTAGATGAT-GCCATCTGCTTAAG-3' (-541 to -524); mDX5, 5'-AATCTAGATTCCCAGGGCGAGCCCGT-3' (-569 to -586); mDX6, 5'-AATCTAGAGGTTGGGCTTGACGT-GAG-3' (-562 to -545); and mDX7, 5'-AATCTA-GAGGGCTTGACGTGAGGATGCCATCTGCTTAA-3'
(-558 to -545/-540 to -525). DNA fragments were amplified from plasmid pCAT-HD1G-D (30) with F1/mDX1 and R4/mDX4 for Acent, with F1/mDX1 and R4/mDX2 for AAP-2, with F1/mDX5 and R4/mDX6 for APRE1, with F1/mDX3 and R4/mDX4 for APRE2, and with F1/mDX5 and R4/mDX7 for APRE3. The amplified fragments were digested with HindIII/XbaI and with XbaI/PstI and then subcloned into pCAT-Basic (Promega) that had been digested withHindIII/PstI. Acent lacked the region from -580 to -542, AAP-2 lacked the sequence TGCCCCTGG from -580 to -572, APRE1 lacked TTATTA from -568 to -563, APRE2 lacked TGAGTAA from -548 to -542, and APRE3 lacked TTATTAGGTT from -568 to -559 and TAAT from -544 to -541. The integrity of all constructs was verified by restriction analysis and sequencing.
To construct a bacterial expression vector for glutathione S-transferase (GST)-Brn-4 fusion protein, the 2.3-kb BamHIEcoRI fragment of the rat Brn-4 gene (11) was subcloned in pGEX2T (Pharmacia). The fusion protein contains the entire Brn-4 amino acid sequence plus three extra residues at the junction. The bacterial extract containing the fusion protein was prepared according to the supplier's recommendations.
CAT Assay. CAT assays were conducted essentially as described (5, 33) . Plasmids were prepared using Qiagen (Chatsworth, CA) plasmid kits, and their respective purities and concentrations were checked by photodensitometry. Transfections were done by the calcium phosphate coprecipitation method using mammalian transfection kits (Stratagene). Transfection efficiency was verified by pCH110 (Pharmacia), a eukaryotic expression vector containing the simian virus early promoter and the Escherichia coli-i3-galactosidase (LacZ) structural gene. Each experiment was repeated at least four times and variations in transfection efficiencies were <20%.
Gel Mobility-Shift Assay. Gel mobility-shift assays were performed as described (5, 33) . GST-Bm-4 fusion protein was induced from the bacterial expression vector by isopropyl ,3-Dthiogalactoside in E. coli JM109. Two sets of complementary oligonucleotides, 5'-AGCTCCCTGGGAATTATTAGGTT-GGGCT-3' /5' -AGCTAGCCCAACCTAATAATTC-CCAGGG-3' and 5'-AGCTCTTGACGTGAGTAATGATGC-CATC-3 '/5' -AGCTGATGGCATCATTACTCACGT-CAAG-3', were synthesized for PRE1 and PRE2 probes, respectively. The sequences of mutated oligonucleotides are shown in Fig. 3B . These oligonucleotides were annealed and radiolabeled with [a-32P]dCTP using the Klenow fragment (Takara Shuzo, Kyoto, Japan). The probes (1000 cpm) were incubated with 400 ng of GST-Brn-4 fusion protein in 40 (34) . The Brn-4 antisense oligonucleotide used was 5'-AGCGGGCCACCTCCTTGCTTCCTCCAGT-CAGAGATCGTGGCAGGACGC-3', located between bases 1117-1070 of the rat Brn-4 cDNA (8). Hybridization and washing steps were performed as described (35) . The oligonucleotide probes were bound to ExtrAvidin-peroxidase (Sigma) and visualized with DAB tablets (Sigma). For in situ hybridization using radioisotope, a Brn-4 riboprobe was transcribed in vitro (CLON-TECH kit) from pBluescript containing the BamHI fragment of Brn-4 genomic DNA (11) . For a DIA probe, the PstI-HindIII genomic fragment (30) containing 608 bp from the first ATG was subcloned in the 3'-5' orientation between the HindIII and PstI H-A~~s ites of pBluescript SK, digested with NcoI to excise the nontranslated sequence, and transcribed from the T7 promoter. The hybridization solution had 50% formamide/0.6 M NaCl/10 mM Tris, pH 7.4/1 mM EDTA/1 x Denhardt's solution/100 ,ug/ml E. coli DNA/1 mg/ml yeast tRNA/0.1% SDS. Hybridized slides were washed in 2x SSC -20 ,ug/ml RNase A at 40°C for 60 min followed by 0.1x SSC at 55°C for 40 min.
RESULTS
Localization of the Brn-4 Responsive Element in the DlA Gene.
Initially, cotransfection CAT assays employed a cell line that does not express the DIA gene to rule out the effects of endogenous factors on the reporter plasmids flanked by DIA promoter _#W.
fragments. The neuroblastoma cell line, Neuro2A, was used since it has D2 but no D1 dopamine receptor binding sites (36 The first set of CAT assays was performed with four reporter constructs containing various stretches of the DIA 5'-flanking region (Fig. 1A) sive cis-elements are located within the genomic fragment contained in the shortest construct D (Fig. 1B) 13. difference between DD7 and DD8 (Fig. 2B) . Thus, the entire region between nucleotides -871 and -471 relative to the eSepharose 4B adenosine of the initial methionine codon (30) located between -569 and -563 (PREl), and a single ATTA is located in the reverse orientation between -544 and -541 (PRE2) (Fig. 3A) . We tentatively designated them as PREs (POU responsive elements) because we have found that another POU factor, Oct-2, also transactivates a reporter gene through these elements (data not shown). PRE2 overlaps with the AP-1 consensus sequence.
We next analyzed the putative binding sites of Bm-4 in the DlA gene. Gel mobility-shift assays using GST-Brn-4 fusion protein revealed that Bm-4 can bind to both candidate sequences (Fig. 3 C, lane 1, and D, lane 1, respectively) but not to the AP-2 binding site or other non-POU consensus sequences (data not shown).
The highest complex with GST-Brn-4 was judged specific because no similarly shifted band was observed when GST protein itself was used as negative control (Fig. 3 C, lane 8 , and D, lane 8) and because it was specifically inhibited by PRE1 or PRE2 oligonucleotides but not by the mutated oligonucleotides (ml to m4) lacking the ATTA motif ( Fig. 3 B-D) . Based on the GST-Brn-4 binding sequences in the DIA gene, the enhancer activity could be localized more precisely. Reporter plasmids lacking PRE1, PRE2, or AP-2 (designated as APRE1, APRE2, and AAP-2, respectively) and another lacking both PRE1 and PRE2 (designated APRE3) were constructed from plasmid pCAT-HDlG-D (30) and used for cotransfection assays with the expression vector pCMV-Brn-4. The enhancement by Bm-4 was clearly reduced by deleting either PRE1 or PRE2 but not the AP-2 consensus sequence and was completely abolished by deleting both PRE1 and PRE2 (Fig. 4B) . These functional analyses are in accordance with the data from DNA-protein found predominantly in the striosomes of the caudate-putamen with a small number in the matrix (Fig. 5 A and B) . This finding is in agreement with previous data derived from binding (38) and in situ hybridization studies (35) . Second, in situ hybridization using Bm-4 and DiA probes on adjacent tissue sections clearly Proc. Natl. Acad. Sci. USA 93 (1996) 11937 demonstrated colocalization of these two gene transcripts at the cellular level within the rat striatum (Fig. 5 C-H 4) probes, respectively. A specific band was supershifted by Bm-4 antiserum (lanes 2 and 4) . A weak band (white arrowhead) was shifted by the antiserum (small white arrowhead), which could correspond to a degraded Brn-4 protein. Non-specific bands are indicated by NS. periment showed supershifted complexes of striatal Brn-4 with PRE1 or PRE2 (Fig. 5J) (44, 45) . Thus, careful neurologic and psychologic evaluations of those patients are important, since knock-out of the DiA dopamine receptor gene causes only functional changes rather than neuronal death or gross morphological anomalies in the nervous system (46, 47 
